Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Raskob, Gary
One or more keywords matched the following items that are connected to Raskob, Gary
Item TypeName
Concept Fibrinolytic Agents
Academic Article Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.
Academic Article Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial.
Academic Article Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials.
Academic Article Apixaban for extended treatment of venous thromboembolism.
Academic Article Anticoagulants and thrombolysis in the treatment of pulmonary embolism.
Academic Article Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer.
Academic Article Self-managed long-term low-molecular-weight heparin therapy: the balance of benefits and harms.
Academic Article Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose-response study.
Academic Article Apixaban after hip or knee arthroplasty versus enoxaparin: efficacy and safety in key clinical subgroups.
Academic Article New paradigms in venous thromboprophylaxis of medically ill patients.
Academic Article Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Academic Article Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Academic Article Home therapy of venous thrombosis with long-term LMWH versus usual care: patient satisfaction and post-thrombotic syndrome.
Academic Article Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial.
Academic Article Hirudin versus heparin and low-molecular-weight heparin: and the winner is...
Search Criteria
  • Fibrinolytic Agents